NVS Related Earnings News
-
Novartis (NVS) Tops Q4 EPS by 8c; Sees Lower Core Income in FY13
-
Novartis (NVS) Misses Q3 EPS by 2c
-
Jefferies Upgrades Onyx Pharmaceuticals (ONXX) to Buy; FDA Approves Kyprolis; Takeover Speculation Intensifies
-
Novartis (NVS) Tops Q2 EPS by 9c; Revs Heavy
-
Auriga Maintains a 'Buy' on Perrigo Co. (PRGO); Accumulate Shares on Weakness
-
Novartis (NVS) Misses Q1 EPS by 5c
-
Novartis (NVS) Misses Q3 EPS by 6c, Sales Miss Expectations, Offers Q4 Outlook
-
Novartis AG ADS (NVS) Tops Q2 EPS by 8c
-
Novartis AG (NVS) Tops Q1 Views; Reaffirms Outlook
-
Highlights From AAPL's Q4 Conference Call: Set New All-Time Records for Mac, iPhone and iPad Sales
-
Sanofi-Aventis (SNY) Cuts Outlook Amid Generic Lovenox Approval; Analysts Mixed
-
Array Biopharma (ARRY) Reports Smaller-Than-Expected Q3 Loss; CEO Comments on Potential Milestone Payments From Partners
-
Alcon (ACL) Reports Strong Q4 Sales; Guides In-line for FY '10
-
Novartis (NVS) Reports Rise In Profits and Names New CEO
-
Gen-Probe (GPRO) Extends Blood Screening Collaboration with Novartis (NVS); Guides In-line with FY09
-
Human Genome Sciences (HGSI) Substantial Progress Toward Commercialization
-
Novartis AG (NVS) Misses Q3 EPS by 3c
-
SGX Pharmaceuticals (SGXP) Reports Q1 Profit
-
Endo Pharmaceuticals (ENDP) Announces Licensing Agreement with Novartis; Revises FY08 Guidance
-
Novartis AG (NVS) Reports Q4 EPS of $0.70
-
Novartis AG (NVS) Tops Q3 Views
-
Novartis AG (NVS) Tops Q1 EPS by 11c
-
NVS Tops Q2 EPS Views
-
PDII Warns Big for FY05; 1M Share Buyback
Back to NVS Stock Lookup
